Near infrared spectroscopy and process analytical technology to master the process of busulfan paediatric capsules in a university hospital.
The prescription of unlicensed oral medicines in paediatrics leads the hospital pharmacists to compound hard capsules, such as busulfan, an alkylating agent prescribed in preparative regimens for bone marrow transplantation. In this study, we have investigated how the general principle of process analytical technology (PAT) can be implemented at the small size of our hospital pharmacy manufacturing unit. Near infrared spectroscopy (NIRS) was calibrated for raw material identification, blend uniformity analysis and final content uniformity of busulfan hard capsules of 11 different strengths. Measurements were performed on capsules from 2 to 40 mg (n=440). After optimisation, accuracy and linearity of the NIRS quantitative method was demonstrated after comparison with a previously validated quantitative high performance thin layer chromatography (HPTLC) method. Such a comparison led to attractive NIRS precision: +/-0.7 to +/-1.0 mg for capsules from 2 to 40 mg, respectively. As NIRS is a rapid and non-destructive technique, the individual control of a whole batch of busulfan paediatric capsules intended to be administrated is possible. Actually, mastering the process of busulfan paediatric capsules with the NIRS integrated into the notion of PAT is a powerful analytical tool to assess the process quality and to perform content uniformity of at least 5mg busulfan-containing capsules.
Paris
I
I
Department of Pharmacy, Robert Debré Hospital (AP-HP), 48 Boulevard Sérurier, 75935 Paris Cedex 19, France.
Janoly-Dumenil
A
A
Paci
A
A
Mercier
L
L
Bourget
P
P
Brion
F
F
Chaminade
P
P
Rieutord
A
A
D000477:Alkylating Agents / Q000032:analysis*; D002066:Busulfan / Q000032:analysis*; D002214:Capsules; D002648:Child; D002851:Chromatography, High Pressure Liquid; D006785:Hospitals, University; D006801:Humans; D010607:Pharmacy Service, Hospital; D011786:Quality Control; D019265:Spectroscopy, Near-Infrared / Q000379:methods*
D000477:Alkylating Agents; D002214:Capsules; D002066:Busulfan